Clinical Research Directory

Browse clinical research sites, groups, and studies.

Sites Groups Studies

Back to Studies

RECRUITING

NCT06411717

A Clinical Trial to Evaluate the Efficacy and Safety of Defocusing Lenses in Delaying Myopia Progression

Sponsor: Suzhou Care-Real Medical Technology Co., Ltd.

View on ClinicalTrials.gov

Summary

The objective of this clinical trial was to evaluate the efficacy and safety of defocusing lenses for delaying myopia progression in children and adolescents. A total of 156 subjects meeting the requirements of the study protocol were included. During the study, subjects were required to wear the test product (defocus lens A or defocus lens B) or the control product (aspheric lens) for 12 months, and regular follow-up was required during the wearing process, including various ophthalmological examinations and subjective feelings about wearing the lens. During the study period, the product status, ocular conditions, adverse events and serious adverse events were continuously observed to evaluate the safety and effectiveness of the test product in clinical use.

Official title: A Prospective, Single-center, Randomized, Double-blind, Controlled, Optimal Clinical Study to Evaluate the Efficacy and Safety of Defocusing Lenses in Delaying Myopia Progression

Key Details

Gender

All

Age Range

8 Years - 13 Years

Study Type

INTERVENTIONAL

Enrollment

156

Start Date

2024-04-07

Completion Date

2026-03-07

Last Updated

2024-05-14

Healthy Volunteers

Conditions

Myopia

Interventions

DEVICE

Microstructure lens A

Subjects randomized to Trial Group A will be required to wear microstructural lens A (microstructural design type with low defocus ratio) for 12 months

DEVICE

Microstructure lens B

Subjects randomized to Trial B will be required to wear microstructural lens B (high defocus ratio microstructural design type) for 12 months

OTHER

Control group

Subjects randomized to the control group will be required to wear aspherical single-light lenses for 12 months

Inclusion Criteria: Participants must meet all criteria to be enrolled in the study at the screening visit: 1. Age 8\~13 years old (including boundary values), gender is not limited; 2. The spherical degree of subjective optometry in both eyes with cycloplegic muscle paralysis was between -1.00D and -6.00D (including the boundary value) (based on the mean value of subjective optometry), and the equivalent spherical difference of both eyes was less than 1.50D; 3. Optimal corrected visual acuity ≥1.0 in left and right eye after ciliary muscle paralysis; 4. In both eyes with cycloplegia, the degree of the column lens was ≤1.50 days; 5. Voluntarily participate in the clinical study, sign the informed consent, and obtain the written consent of the guardian; Exclusion Criteria: Subjects who met any of the following criteria at the time of the screening visit were excluded from the study: 1. Have a history of eye trauma or intraocular surgery; 2. Abnormal results of slit-lamp examination (see Annex 1 for details); 3. fundus examination results ≥ grade 2 (see Annex 1 for details); 4. Intraocular pressure \< 10mmHg or \> 21mmHg or intraocular pressure difference ≥5mmHg; 5. Patients with other eye diseases, such as uveitis and other inflammation, glaucoma, cataract, fundus disease, eye tumors, eye trauma, dominant strabismus, and any eye lesions affecting visual function; 6. Associated diseases that may affect the eye (such as acute and chronic sinusitis, diabetes, Down syndrome, rheumatoid arthritis, etc.); 7. suffering from a mental disorder or other disease that the researcher deems unsuitable for wearing frame glasses; 8. Use specially designed myopia control lenses such as hard contact lenses (including care products), multifocal contact lenses, progressive multifocal lenses, and atropine drugs within 1 month before screening or during the planned study period; 9. Participating in other clinical trials within 3 months prior to screening; 10. Those who cannot perform regular eye examination; 11. Other investigators consider it inappropriate to participate in this clinical study.

Locations (1)

The First Affiliated Hospital of Soochow University

Suzhou, District, Suzhou City, Jiangsu Province, China